Open AccessFive-Years Tigecycline Experience an Analysis of Real-Life Data
Author(s) -
Fatih Temoçin,
Necla Tülek,
Şirin Hekimoğlu,
Tuba Ilgar,
Cemal Bulut,
Fatma Şebnem Erdinç,
Günay Tuncer Ertem,
Çiğdem Ataman Hatipoğlu,
Sami KINIKLI
Publication year - 2018
Publication title -
medical bulletin of haseki
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.113
H-Index - 4
eISSN - 2147-2688
pISSN - 1302-0072
DOI - 10.4274/haseki.42713
Subject(s) - tigecycline , data science , medicine , computer science , biology , microbiology and biotechnology , antibiotics
Telif Hakkı 2018 Sağlık Bilimleri Üniversitesi Haseki Eğitim ve Araştırma Hastanesi Haseki Tıp Bülteni, Galenos Yayınevi tarafından basılmıştır. AddressforCorrespondence/Yaz›flmaAdresi:Fatih Temocin Yozgat City Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Yozgat, Turkey Phone: +90 505 841 03 48 E-mail: ftemucin@yahoo.com.tr ORCID ID: orcid.org/0000-0002-4819-8242 Received/GeliflTarihi:16 July 2017 Accepted/KabulTari hi:09 November 2017 Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia. In our study, we examined the efficacy of tigecycline in clinical practice and reported real life data from our hospital over a period of five years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom